RecallReported October 28, 2026
Class II recall by Shenzhen Techdow Pharmaceutical Co., Ltd.
Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, P…
FDA's enforcement report of October 28, 2026 lists a Class II recall by Shenzhen Techdow Pharmaceutical Co., Ltd. of Shenzhen, China. Product: Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, P…. Status: Ongoing.
On the record
- Recalling firm
- Shenzhen Techdow Pharmaceutical Co., Ltd.
- Location
- Shenzhen, China
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0050-2027
- Product type
- Drugs
- Brand names
- HEPARIN SODIUM
- Generic names
- HEPARIN SODIUM
- Recall initiated
- 2026-10-01
- Reported by FDA
- 2026-10-28
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch Shenzhen Techdow Pharmaceutical Co., Ltd
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Shenzhen Techdow Pharmaceutical Co., Ltd.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.